|
Journal of Lipid Research, Vol. 40, 1695-1700, September 1999
Copyright © 1999 by Lipid Research, Inc.
Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins
Wanda Vélez-Carrascoa,
Alice H. Lichtensteina,
P. Hugh R. Barrettb,
Zhiyong Suna,
Gregory G. Dolnikowskia,
Francine K. Weltya, and
Ernst J. Schaefera
a Lipid Metabolism Laboratory, Mass Spectrometry Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, Boston, MA 02111
b Resource Facility for Kinetic Analysis, Center for Bioengineering, University of Washington, Seattle, WA 98195
Correspondence to:
Ernst J. Schaefer
Stable isotope methodology was used to determine the kinetic behavior of apolipoprotein (apo) A-I within the triglyceride-rich lipoprotein (TRL) fraction and to compare TRL apoA-I kinetics with that of apoA-I in high density lipoprotein (HDL) and TRL apoB-48. Eight subjects (5 males and 3 females) over the age of 40 were placed on a baseline average American diet and after 6 weeks received a primed-constant infusion of [5,5,5-2H3]-L-leucine for 15 h while consuming small hourly meals of identical composition. HDL and TRL apoA-I and TRL apoB-48 tracer/tracee enrichment curves were obtained by gas chromatography;mass spectrometry. Data were fitted to a compartmental model to determine the fractional secretion rates of apoA-I and apoB-48 within each lipoprotein fraction. Mean plasma apoA-I levels in TRL and HDL fractions were 0.204 ± 0.057 and 134 ± 15 mg/dl, respectively. The mean fractional catabolic rate (FCR) of TRL apoA-I was 0.250 ± 0.069 and HDL apoA-I was 0.239 ± 0.054 pools/day, with mean estimated residence times (RT) of 4.27 and 4.37 days, respectively. The mean TRL apoB-48 FCR was 5.2 ± 2.0 pools/day and the estimated mean RT was 5.1 ± 1.8 h.
Our results indicate that apoA-I is catabolized at a slower rate than apoB-48 within TRL, and that apoA-I within TRL and HDL fractions are catabolized at similar rates.Vélez-Carrasco, W., A. H. Lichtenstein, P. H. R. Barrett, Z. Sun, G. G. Dolnikowski, F. K. Welty, and E. J. Schaefer. Human apolipoprotein A-I kinetics within triglyceride-rich lipoproteins and high density lipoproteins. J. Lipid Res. 1999. 40: 1695;1700.
Supplementary key words:
apoA-I, apoB-48, kinetics, stable isotopes, TRL, compartmental analysis

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Verges, E. Florentin, S. Baillot-Rudoni, J.-M. Petit, M. C. Brindisi, J.-P. Pais de Barros, L. Lagrost, P. Gambert, and L. Duvillard
Rosuvastatin 20 mg restores normal HDL-apoA-I kinetics in type 2 diabetes
J. Lipid Res.,
June 1, 2009;
50(6):
1209 - 1215.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. R. Matthan, S. M. Jalbert, P. H. R. Barrett, G. G. Dolnikowski, E. J. Schaefer, and A. H. Lichtenstein
Gender-Specific Differences in the Kinetics of Nonfasting TRL, IDL, and LDL Apolipoprotein B-100 in Men and Premenopausal Women
Arterioscler. Thromb. Vasc. Biol.,
October 1, 2008;
28(10):
1838 - 1843.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Santos, E. J. Schaefer, B. F. Asztalos, E. Polisecki, J. Wang, R. A. Hegele, L. R. C. Martinez, M. H. Miname, C. E. Rochitte, P. L. Da Luz, et al.
Characterization of high density lipoprotein particles in familial apolipoprotein A-I deficiency
J. Lipid Res.,
February 1, 2008;
49(2):
349 - 357.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ramakrishnan
Studying apolipoprotein turnover with stable isotope tracers: correct analysis is by modeling enrichments
J. Lipid Res.,
December 1, 2006;
47(12):
2738 - 2753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Sun, F. K Welty, G. G Dolnikowski, A. H Lichtenstein, and E. J Schaefer
Effects of a National Cholesterol Education Program Step II Diet on apolipoprotein A-IV metabolism within triacylglycerol-rich lipoproteins and plasma
Am. J. Clinical Nutrition,
September 1, 2001;
74(3):
308 - 314.
[Abstract]
[Full Text]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|